Q Linea AB logo

QLINEA - Q Linea AB Share Price

SEK63.5 -0.5  -0.8%

Last Trade - 13/09/19

Sector
Healthcare
Size
Small Cap
Market Cap £122.2m
Enterprise Value £99.9m
Revenue £127k
Position in Universe 675th / 1473
Bullish
Bearish
Unlock QLINEA Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

QLINEA Revenue Unlock QLINEA Revenue

Net Income

QLINEA Net Income Unlock QLINEA Revenue

Normalised EPS

QLINEA Normalised EPS Unlock QLINEA Revenue

PE Ratio Range

QLINEA PE Ratio Range Unlock QLINEA Revenue

Dividend Yield Range

QLINEA Dividend Yield Range Unlock QLINEA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
QLINEA EPS Forecasts Unlock QLINEA Revenue
Profile Summary

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Public Since December 7, 2018
No. of Shareholders: n/a
No. of Employees: 61
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 23,117,963
Free Float (0.0%)
Eligible for
ISAs
SIPPs
QLINEA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for QLINEA
Upcoming Events for QLINEA
Similar to QLINEA
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.